• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

B&L launches microsurgical system

Article

Bausch & Lomb introduced its microsurgical system for cataract (Stellaris Vision Enhancement System) in the European market at the annual meeting of the European Society of Cataract and Refractive Surgeons in Stockholm, Sweden.

Rochester, NY-Bausch & Lomb introduced its microsurgical system for cataract (Stellaris Vision Enhancement System) in the European market at the annual meeting of the European Society of Cataract and Refractive Surgeons in Stockholm, Sweden.

The system is appropriate for all techniques, particularly 1.8-mm biaxial and 1.8-mm coaxial procedures, according to the company. Features include fluidics management technology that allows surgeons to choose either a flow-vacuum module or an advanced vacuum module; a six-crystal phacoemulsification handpiece designed to be ergonomic; a wireless-enabled, dual-linear foot pedal; and a high-definition touch-screen display.

"The system lets surgeons operate at [their] own pace when using smaller incisions, without compromising speed or efficiency, while delivering excellent optical outcomes. It limits complications, reduces the rehabilitation time for the patient, and provides excellent results directly after surgery," said H. Burkhard Dick, MD, of the Center for Vision Science at Ruhr University, Bochum, Germany. "After more than 50 cases . . . I continue to be impressed."

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
Elizabeth Yeu, MD, highlights from a corneal case report for a patient undergoing the triple procedure
© 2024 MJH Life Sciences

All rights reserved.